DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Aspartame is an investigational drug.
There have been 5 clinical trials for Aspartame. The most recent clinical trial was a Phase 2 trial, which was initiated on June 10th 2019.
The most common disease conditions in clinical trials are Diabetes Mellitus, Hyperglycemia, and Obesity, Abdominal. The leading clinical trial sponsors are West China Hospital, Medical University of South Carolina, and University of Toronto.
There are two US patents protecting this investigational drug and thirty-four international patents.
Recent Clinical Trials for Aspartame
|Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy||Universal Integrated Corp.||Phase 3|
|Effects of Fenofibrate Therapy in Diabetic Nephropathy||National Medical Research Council (NMRC), Singapore||Phase 3|
|Effects of Fenofibrate Therapy in Diabetic Nephropathy||Singapore General Hospital||Phase 3|
Top disease conditions for Aspartame
Top clinical trial sponsors for Aspartame
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Aspartame||Start Trial||Infusion methods and products||Ocean Spray Cranberries, Inc. (Lakeville-Middleboro, MA)||Start Trial|
|Aspartame||Start Trial||Cyclic boronic acid ester derivatives and methods of making the same||Rempex Pharmaceuticals, Inc. (San Diego, CA)||Start Trial|
|Aspartame||Start Trial||Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same||KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Aspartame||World Intellectual Property Organization (WIPO)||2011127198||2030-04-06||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|